Interestingly, Ma et al. demonstrated that miR-130b promotes CD133-positive tumor-initiating HCC cell growth and self-renewal ability by suppressing tumor protein 53-induced nuclear protein 1 (TP53INP1) expression [149]. The gene discussed is PROM1; the disease is hepatocellular carcinoma.